Join Chris Walsh, CEO at Acadia as he discusses how the OTC Derivatives industry is mainstreaming UMR compliance and starting to move towards optimizing their performance. Chris shares his insights on how the industry is adapting to a more holistic approach to risk, margin and collateral -coining the phrase Optimal Margin Management.
Recorded and produced by Lansons
Listen time – 13 minutes
John Pucciarelli, Head of Industry and Regulatory Strategy and Stuart Smith, Co-Head of Business Development at Acadia sit down to discuss the regulatory outlook...
In this episode, industry experts explore key market developments shaping the financial landscape in 2025. The discussion covers the evolving ISDA SIMM model as...
In this insightful episode, John Pucciarelli and Stuart Smith dive into two pivotal regulatory developments shaping the financial landscape. They explore recent guidance from...